Protein tyrosine phosphorylation is a post-translational modification that regulates protein structure to modulate demic organisms’homeostasis and function.This physiological process is regulated by two enzyme famili...Protein tyrosine phosphorylation is a post-translational modification that regulates protein structure to modulate demic organisms’homeostasis and function.This physiological process is regulated by two enzyme families,protein tyrosine kinases(PTKs)and protein tyrosine phosphatases(PTPs).As an important regulator of protein function,PTPs are indispensable for maintaining cell intrinsic physiology in different systems,as well as liver physiological and pathological processes.Dysregulation of PTPs has been implicated in multiple liver-related diseases,including chronic liver diseases(CLDs),hepatocellular carcinoma(HCC),and liver injury,and several PTPs are being studied as drug therapeutic targets.Therefore,given the regulatory role of PTPs in diverse liver diseases,a collated review of their function and mechanism is necessary.Moreover,based on the current research status of targeted therapy,we emphasize the inclusion of several PTP members that are clinically significant in the development and progression of liver diseases.As an emerging breakthrough direction in the treatment of liver diseases,this review summarizes the research status of PTP-targeting compounds in liver diseases to illustrate their potential in clinical treatment.Overall,this review aims to support the development of novel PTP-based treatment pathways for liver diseases.展开更多
基金supported by National Natural Science Foundation of China(81930108 to Guang Liang)Zhejiang Provincial Key Scientific Project(2021C03041 to Guang Liang,China).
文摘Protein tyrosine phosphorylation is a post-translational modification that regulates protein structure to modulate demic organisms’homeostasis and function.This physiological process is regulated by two enzyme families,protein tyrosine kinases(PTKs)and protein tyrosine phosphatases(PTPs).As an important regulator of protein function,PTPs are indispensable for maintaining cell intrinsic physiology in different systems,as well as liver physiological and pathological processes.Dysregulation of PTPs has been implicated in multiple liver-related diseases,including chronic liver diseases(CLDs),hepatocellular carcinoma(HCC),and liver injury,and several PTPs are being studied as drug therapeutic targets.Therefore,given the regulatory role of PTPs in diverse liver diseases,a collated review of their function and mechanism is necessary.Moreover,based on the current research status of targeted therapy,we emphasize the inclusion of several PTP members that are clinically significant in the development and progression of liver diseases.As an emerging breakthrough direction in the treatment of liver diseases,this review summarizes the research status of PTP-targeting compounds in liver diseases to illustrate their potential in clinical treatment.Overall,this review aims to support the development of novel PTP-based treatment pathways for liver diseases.
